Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Driver, "A Cure for Cancer Treatment," Launches in US and China

publication date: Sep 7, 2018

Driver, a US-China startup, which bills itself as "the cure for cancer treatment," offers to match cancer patients with the best treatment for their particular disease, including clinical trials of novel drugs. After three years in development, the company will start enrolling patients, charging $3000 in a one-time upfront payment and a $20 monthly fee. So far, Driver has raised $90 million, including an investment from Li Ka-shing, the Hong Kong billionaire who founded the Hutchison conglomerate. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital